SCALISE, Mariafrancesca
 Distribuzione geografica
Continente #
NA - Nord America 4.047
AS - Asia 3.757
EU - Europa 2.311
SA - Sud America 1.121
AF - Africa 330
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.585
Nazione #
US - Stati Uniti d'America 3.862
SG - Singapore 1.543
BR - Brasile 775
CN - Cina 653
VN - Vietnam 618
UA - Ucraina 510
DE - Germania 507
IT - Italia 471
FR - Francia 263
HK - Hong Kong 193
SN - Senegal 182
SE - Svezia 130
AR - Argentina 126
IN - India 118
FI - Finlandia 98
CA - Canada 92
TR - Turchia 88
KR - Corea 85
BD - Bangladesh 74
AT - Austria 69
IQ - Iraq 63
MX - Messico 57
ID - Indonesia 52
GB - Regno Unito 51
EC - Ecuador 50
PK - Pakistan 50
RU - Federazione Russa 41
CO - Colombia 37
ZA - Sudafrica 37
VE - Venezuela 29
JP - Giappone 28
CL - Cile 27
SA - Arabia Saudita 26
MA - Marocco 25
BE - Belgio 24
PE - Perù 24
PL - Polonia 24
UZ - Uzbekistan 24
NL - Olanda 23
ES - Italia 21
PH - Filippine 20
TN - Tunisia 18
BO - Bolivia 17
PY - Paraguay 17
UY - Uruguay 17
DZ - Algeria 15
EG - Egitto 15
MY - Malesia 14
KZ - Kazakistan 12
NP - Nepal 12
AZ - Azerbaigian 11
AE - Emirati Arabi Uniti 10
AU - Australia 9
DO - Repubblica Dominicana 9
JO - Giordania 8
HU - Ungheria 7
LB - Libano 7
NG - Nigeria 7
RO - Romania 7
BY - Bielorussia 6
IE - Irlanda 6
KE - Kenya 6
NI - Nicaragua 6
TH - Thailandia 6
AL - Albania 5
BG - Bulgaria 5
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
EU - Europa 5
MN - Mongolia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
CH - Svizzera 4
CR - Costa Rica 4
ET - Etiopia 4
JM - Giamaica 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
PT - Portogallo 4
GA - Gabon 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
KH - Cambogia 3
LT - Lituania 3
LY - Libia 3
MD - Moldavia 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
MT - Malta 2
QA - Qatar 2
SV - El Salvador 2
Totale 11.557
Città #
Singapore 680
Chandler 455
San Jose 396
Jacksonville 289
Ashburn 260
Dallas 240
Ho Chi Minh City 216
Boardman 196
Hong Kong 182
Dakar 181
San Mateo 177
Beijing 171
Dearborn 132
Hanoi 127
Munich 121
Redmond 111
New York 106
Lauterbourg 91
Seoul 84
Shanghai 84
Lawrence 80
Roxbury 80
Bremen 76
Rende 72
São Paulo 70
Hefei 61
Helsinki 61
Ann Arbor 60
Izmir 58
Los Angeles 56
Cosenza 55
Des Moines 55
Vienna 51
Ottawa 50
Inglewood 47
The Dalles 44
Columbus 43
Santa Clara 41
Brooklyn 39
Da Nang 38
Florence 38
Ogden 33
Council Bluffs 32
Turku 32
Haiphong 31
Orem 28
Secaucus 27
Wilmington 27
Baghdad 26
Pune 26
Rome 26
Tokyo 25
Jakarta 24
Rio de Janeiro 24
Seattle 24
Brussels 23
Guangzhou 23
Falkenstein 21
Tashkent 19
Warsaw 19
Dhaka 18
Frankfurt am Main 18
Toronto 18
Buenos Aires 16
Cambridge 16
Chennai 16
Mexico City 16
San Francisco 16
Biên Hòa 15
Guayaquil 15
Johannesburg 15
Lima 15
Naples 15
Curitiba 14
Grafing 14
Salvador 14
Belo Horizonte 13
Brasília 13
Guarulhos 13
Quito 13
Lahore 12
London 12
Montreal 12
Asunción 11
Manchester 11
Mumbai 11
Redwood City 11
Tianjin 11
Amsterdam 10
Baku 10
Cairo 10
Cape Town 10
Erbil 10
Medellín 10
Milan 10
Montevideo 10
Nanjing 10
Campinas 9
Caracas 9
Falls Church 9
Totale 6.475
Nome #
LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter 289
ATP modulates SLC7A5 (LAT1) synergistically with cholesterol 203
Characterization of the CAT2 transporter from Solanum lycopersicum (Tomato). 189
The Human SLC1A5 (ASCT2) amino acid transporter: From function to structure and role in cell biology 186
Carnitine Traffic in Cells. Link With Cancer 184
Insights into the transport side of the human SLC38A9 transceptor 183
Bacterial production and reconstitution in proteoliposomes of Solanum lycopersicum CAT2: a transporter of basic amino acids and organic cations 173
Regulatory Aspects of the Vacuolar CAT2 Arginine Transporter of S. lycopersicum: Role of Osmotic Pressure and Cations 172
Cloning, Large Scale Over-Expression in E-coli and Purification of the Components of the Human LAT 1 (SLC7A5) Amino Acid Transporter 161
Chemical Targeting of Membrane Transporters: Insights into Structure/Function Relationships 159
Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter. 157
Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs 157
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter 156
Glutamine transport and mitochondrial metabolism in cancer cell growth 153
Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods 151
Effect of cholesterol on the organic cation transporter OCTN1 (SLC22A4) 151
Cys site-directed mutagenesis of the human SLC1A5 (ASCT2) transporter: Structure/function relationships and crucial role of Cys467 for redox sensing and glutamine transport 150
Functional and Molecular Effects of Mercury Compounds on the Human OCTN1 Cation Transporter: C50 and C136 Are the Targets for Potent Inhibition 148
Chemical approaches for studying the biology and pharmacology of membrane transporters: The histidine/large amino acid transporter slc7a5 as a benchmark 148
Bacterial over-expression of functionally active human CT2 (SLC22A16) carnitine transporter 146
Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter 146
Cysteine 467 of the ASCT2 Amino Acid Transporter Is a Molecular Determinant of the Antiport Mechanism 145
Amino acids transport and metabolism 2.0 144
Mitochondrial Carnitine/Acylcarnitine Transporter, a Novel Target of Mercury Toxicity 143
A targetable antioxidant defense mechanism to EZH2 inhibitors enhances tumor cell vulnerability to ferroptosis 140
The human SLC7A5 (LAT1): The intriguing histidine/large neutral amino acid transporter and its relevance to human health 140
The Human SLC1A5 Neutral Amino Acid Transporter Catalyzes a pH-Dependent Glutamate/Glutamine Antiport, as Well 139
Over-Expression in E. coli and Purification of the Human OCTN2 Transport Protein 137
Carnitine traffic and human fertility 135
Exosomes in inflammation and role as biomarkers 135
ASCT1 and ASCT2: Brother and Sister? 135
OCTN Cation Transporters in Health and Disease: Role as Drug Targets and Assay Development 134
Interaction of Cholesterol With the Human SLC1A5 (ASCT2): Insights Into Structure/Function Relationships 133
Inhibition of the carnitine acylcarnitine carrier by carbon monoxide reveals a novel mechanism of action with non-metal-containing proteins 132
Strategies of Bacterial Over Expression of Membrane Transporters Relevant in Human Health: The Successful Case of the Three Members of OCTN Subfamily 130
Studying interactions of drugs with cell membrane nutrient transporters: New frontiers of proteoliposome nanotechnology 128
Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health 126
Glutamine transport. From energy supply to sensing and beyond 124
Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs 124
Functional and kinetic characterization of the acetylcholine transport catalized by the recombinant human OCTN1 transporter reconstituted in liposomes. 122
Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed in Escherichia coli 121
The involvement of sodium in the function of the human amino acid transporter ASCT2 121
OCTN: A Small Transporter Subfamily with Great Relevance to Human Pathophysiology, Drug Discovery, and Diagnostics 120
Over-expression in Escherichia coli, purification and reconstitution in liposomes of the third member of the OCTN sub-family: The mouse carnitine transporter OCTN3 119
Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris - functional and kinetic asymmetry revealed in proteoliposomes 117
Site directed mutanesis of Cys residues of the human OCTN1 transporter 117
Human OCTN2 (SLC22A5) is down-regulated in virus- and nonvirus-mediated cancer 115
Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring 113
Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2) 113
N-linked Glycosylation of human SLC1A5 (ASCT2) transporter is critical for trafficking to membrane 112
Immuno-detection of OCTN1 (SLC22A4) in He La cells and characterization of transport function 111
Transport mechanism and regulatory properties of the human amino acid transporter ASCT2 (SLC1A5) 111
The Nutraceutical Alliin From Garlic Is a Novel Substrate of the Essential Amino Acid Transporter LAT1 (SLC7A5) 108
The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease 108
SLC1A5 (solute carrier family 1 (neutral amino acid transporter), member 5 108
Glutamine transporters as pharmacological targets: From function to drug design 107
Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes 106
Using liposomes to functionally characterize transport systems for glutamine and neutral amino acids 106
N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98) 104
The Sodium Sialic acid symporter from Staphylococcus aureus has altered substrate specificity 104
OCTN1: A Widely Studied but Still Enigmatic Organic Cation Transporter Linked to Human Pathology and Drug Interactions 104
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation 103
OCTN1 (SLC22A4) displays two different transport pathways for organic cations or zwitterions 102
Strategies for bacterial over-expression of the canonical and variant hOCTN2 transport proteins. 101
The yeast P-pastoris as a tool for large scale production of WT and mutant human amino acid transporter SLC1A5 100
Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder 100
Over-expression and purification of the human OCTN1 and OCTN2 transporters in detergent soluble form 99
Substrate-bound outward-open structure of a Na+-coupled sialic acid symporter reveals a new Na+site 99
Regulation by physiological cations of acetylcholine transport mediated by human OCTN1 (SLC22A4). Implications in the non-neuronal cholinergic system. 97
Production of recombinant human xCT (SLC7A11) and reconstitution in proteoliposomes for functional studies 94
Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19 94
Editorial: Transport of Nutrients, Metabolites and Ions Linked to Bioenergetics: Relevance to Human Pathology 94
Strategies for bacterial expression and large scale purification of human amino acid transporters. 92
OCTN1 (SLC22A4) as a Target of Heavy Metals: Its Possible Role in Microplastic Threats 90
Extracellular Vesicles and Cell Pathways Involved in Cancer Chemoresistance 88
Over-Production of the Human SLC7A10 in E. coli and Functional Assay in Proteoliposomes 87
Strategies of large scale expression and purification of the transport proteins OCTN1 and OCTN2. 87
Strategies for Successful Over-Expression of Human Membrane Transport Systems Using Bacterial Hosts: Future Perspectives 87
Over-expression in E. coli of the mouse OCTN3 (SLC22A21) transporter 86
Strategies of expression of the tran sport proteins OCTN1 and OCTN2 86
NEW INSIGHTS IN FUNCTIONAL PROPERTIES OF THE HUMAN OCTN1 TRANSPORTER: IMPLICATION IN CROHN'S DISEASE 85
Inhibition of the Mitochondrial Carnitine/Acylcarnitine Carrier by Itaconate through Irreversible Binding to Cysteine 136: Possible Pathophysiological Implications 81
The recombinant human OCTN1 transporter catalyses acetylcholine transport in reconstituted liposomes 81
Proteoliposomes as tool for assaying membrane transporter functions and interactions with xenobiotics 81
Over-expression in E. coli and reconstitution in liposomes of the OCTN3 (SLC22A21) transporter. 79
Human OCTN1 transporter as a target for heavy metals: molecular mechanism of interaction. Congresso scientifico Non neuronal cholinergic system, Justus-Liebig-University Giessen 79
IκB kinase β promotes cell survival by Antagonizing p53 functions through ΔNp73α phosphorylation and stabilization 78
Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling 76
LAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism 74
OCTN1 mediates acetylcholine transport in the A549 lung cancer cells: possible pathophysiological implications 72
Novel functional and structural properties of the human OCTN1 transporter: implication in pathophysiology 70
Human papillomavirus type 38 alters wild-type p53 activity to promote cell proliferation via the downregulation of integrin alpha 1 expression 70
Lysine 204 is crucial for the antiport function of the human LAT1 transporter 69
TMBIM5 is the Ca2+ /H+ antiporter of mammalian mitochondria 66
The Link Between the Mitochondrial Fatty Acid Oxidation Derangement and Kidney Injury 66
Structure and mechanism of a tripartite ATP-independent periplasmic TRAP transporter 58
Sialic Acid Derivatives Inhibit SiaT Transporters and Delay Bacterial Growth 57
Editorial: Transport of Nutrients, Metabolites and Ions linked to Bioenergetics: Relevance to Human Pathology, Volume II 55
Production of the human carnitine transporter CT2 (SLC22A16) by bacterial expression and functional characterization in proteoliposomes 54
Inflammation and Organic Cation Transporters Novel (OCTNs) 50
Totale 11.640
Categoria #
all - tutte 62.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 0 0 0 0 70 3 48
2021/2022939 8 128 13 48 88 22 8 214 18 8 143 241
2022/20231.191 131 169 24 148 180 95 13 168 129 22 77 35
2023/2024724 59 41 48 30 57 145 33 51 58 38 40 124
2024/20251.938 79 218 62 97 166 175 131 127 203 105 214 361
2025/20265.312 660 223 498 391 1.065 508 763 303 532 369 0 0
Totale 11.800